References

The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide.

10.1002/ijc.35278 · 2025 · External reference

Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer.

10.1056/nejmoa2409408 · 2025 · External reference

Hybrid minimally invasive esophagectomy for esophageal cancer.

10.1056/nejmoa1805101 · 2019 · External reference

Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

10.1016/s0140-6736(12)60516-9 · 2012 · External reference

Quality of life and late complications after minimally invasive compared to open esophagectomy: results of a randomized trial.

10.1007/s00268-015-3100-y · 2015 · External reference

Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial.

10.1097/sla.0000000000003031 · 2019 · External reference

Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis.

10.1097/sla.0000000000002824 · 2019 · External reference

Impact of lymph node yield on overall survival in patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy for cancer: a population-based cohort study in the Netherlands.

10.1097/sla.0000000000002389 · 2017 · External reference

The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

10.1097/sla.0b013e318188c474 · 2008 · External reference

Comparing outcomes following open, hybrid, minimally invasive, and robotic-assisted esophagectomy: a systematic review.

10.1016/j.ejso.2025.110531 · 2026 · External reference

Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis.

10.1097/sla.0000000000005782 · 2023 · External reference

CONSORT 2025 statement: updated guideline for reporting randomised trials.

10.1016/s0140-6736(25)00672-5 · 2025 · External reference

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).

10.1186/s12885-021-08780-x · 2021 · External reference

Classification of adenocarcinoma of the oesophagogastric junction.

10.1046/j.1365-2168.1998.00940.x · 1998 · External reference

Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.

10.1186/s12885-019-5761-7 · 2019 · External reference

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

10.1097/01.sla.0000133083.54934.ae · 2004 · External reference

Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial).

10.1093/bjs/znae143 · 2024 · External reference

Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.

10.1016/s2468-1253(25)00207-9 · 2025 · External reference

Total number of resected lymph nodes predicts survival in esophageal cancer.

10.1097/sla.0b013e31817bbe59 · 2008 · External reference

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

10.1200/jco.2005.14.621 · 2005 · External reference

The effect of postoperative complications after minimally invasive esophagectomy on long-term survival: an international multicenter cohort study.

10.1097/sla.0000000000003772 · 2021 · External reference

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction—a randomized phase III joint study of the AIO, ARO and DGAV.

10.1186/s12885-020-07388-x · 2020 · External reference

Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.

10.1016/s1470-2045(25)00027-0 · 2025 · External reference